Ovary adenocarcinoma tissue array
To Order Contact us: lieven@wlsolutions.be
Lung adenocarcinoma tissue array |
||
LC641 | each | EUR 198 |
Description: Lung adenocarcinoma tissue array, including pathology grade, TNM/Stage, 64 cases/ 64 cores |
Lung adenocarcinoma tissue array |
||
LC706a | each | EUR 306 |
Description: Lung adenocarcinoma tissue array, including TNM, clinical stage and pathology grade, 75 cases/75 cores, replaced by LC706a |
Lung adenocarcinoma tissue array |
||
LC706b | each | EUR 306 |
Description: Lung adenocarcinoma tissue array, including pathology grade, TNM and clinical stage, 75 cases/75 cores, replacing LC706a |
Colon adenocarcinoma tissue array |
||
CO1251 | each | EUR 270 |
Description: Colon adenocarcinoma tissue array, including ulcer, uplift and infiltrating type adenocarcinoma, with pathology grade, TNM/Stage ( AJCC 8th edition) and MMR (MLH1/PMS2/MSH2/MSH6) IHC results, 125 cases/125cores (core size 1.5mm), Recent Year Collection |
Colon adenocarcinoma tissue array |
||
CO1501 | each | EUR 258 |
Description: Colon adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores |
Colon adenocarcinoma and rectum adenocarcinoma tissue array |
||
GI1701 | each | EUR 414 |
Description: Colon adenocarcinoma and rectum adenocarcinoma tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 85 cases/170 cores (1.0mm), replacing BC000110 |
Rectum adenocarcinoma tissue array |
||
RE1501 | each | EUR 258 |
Description: Rectum adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores |
Stomach adenocarcinoma tissue array |
||
BS01011b | each | EUR 270 |
Description: Stomach adenocarcinoma tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing BS01011a |
Stomach adenocarcinoma tissue array |
||
ST1502 | each | EUR 258 |
Description: Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores |
Colon adenocarcinoma and metastatic adenocarcinoma tissue array |
||
CO953a | each | EUR 1434 |
Description: Colon adenocarcinoma and metastatic adenocarcinoma tissue array, with matched colon tissue, including survival data, pathology grade, TNM and clinical stage, 39 cases/96 cores, replacing CO953 |
Colon adenocarcinoma tissue array with colon tissue |
||
CO1201 | each | EUR 348 |
Description: Colon adenocarcinoma tissue array with colon tissue, with pathology grade, TNM/Stage, 120 cases/120 cores (core size 1.0mm), replacing BC051110c |
Prostate adenocarcinoma test tissue array |
||
T191b | each | EUR 66 |
Description: Prostate adenocarcinoma test tissue array, with prostate control tissues, pathology grade, TNM and clinical stage (AJCC 8.0), 6 cases/24 cores, replacing T191a (1.5mm) |
Lymphatic metastatic adenocarcinoma tissue array |
||
LY803 | each | EUR 306 |
Description: Lymphatic metastatic adenocarcinoma tissue array, 80 cases/80 cores |
Colon adenocarcinoma (grade I) tissue array |
||
CO351a | each | EUR 168 |
Description: Colon adenocarcinoma (grade I) tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores, replacing CO351 |
Colon adenocarcinoma stage IV tissue array |
||
CO489a | each | EUR 198 |
Description: Colon adenocarcinoma stage IV tissue array, including TNM, clinical stage and pathology grade, non-overlapping with other CO489, 24 cases/ 48 cores |
Colon adenocarcinoma (grade II) tissue array |
||
CO963a | each | EUR 258 |
Description: Colon adenocarcinoma (grade II) tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores, replacing CO963 |
Lung adenocarcinoma with lung tissue array |
||
LC402 | each | EUR 270 |
Description: Lung adenocarcinoma with lung tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 30 cases/40 cores (core size 1.5mm) |
Colon adenocarcinoma (grade III) tissue array |
||
CO353 | each | EUR 168 |
Description: Colon adenocarcinoma (grade III) tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores, replaced by CO353a |
Colon adenocarcinoma (grade III) tissue array |
||
CO353a | each | EUR 168 |
Description: Colon adenocarcinoma (grade III) tissue array, including pathology grade, TNM and clinical stage, 35 cases/35 cores, replacing CO353 |
Colon adenocarcinoma with colon tissue array |
||
CO483b | each | EUR 198 |
Description: Colon adenocarcinoma with colon tissue array, including pathology, TNM and clinical stage, 48 cases/48 cores, replacing CO483a |
Normal lung tissue array with adenocarcinoma tissue as control |
||
LCN721 | each | EUR 258 |
Description: Normal lung tissue array with adenocarcinoma tissue as control, including TNM, clinical stage, pathology grade and IHC result, 24 cases/ 72 cores |
Esophagus adenocarcinoma and normal tissue array |
||
ES8011b | each | EUR 306 |
Description: Esophagus adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores (1.5mm), replacing ES8011a |
Endometrioid adenocarcinoma and normal tissue array |
||
T091a | each | EUR 48 |
Description: Endometrioid adenocarcinoma and normal tissue array, including pathology grade, TNM/Stage (AJCC 8.0), 6 cases/24 cores (core size 1.5mm), replacing T091 |
Pancreatic adenocarcinoma with pancreas tissue array |
||
PA1001c | each | EUR 306 |
Description: Pancreatic adenocarcinoma with pancreas tissue array, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 50 cases/100 cores, replacing PA1001b |
Pancreatic adenocarcinoma with pancreas tissue array |
||
PA484a | each | EUR 168 |
Description: Pancreatic adenocarcinoma with pancreas tissue array, including pathology grade, TNM and clinical stage, 24 cases/48 cores (core size2.0mm), replacing PA484 |
Rectum adenocarcinoma tissue array with matched adjacent rectum tissue |
||
RE483 | each | EUR 168 |
Description: Rectum adenocarcinoma tissue array with matched adjacent rectum tissue, including TNM and pathology grade, 16 cases/48 cores |
Lung mucin-producing adenocarcinoma (MPA) tissue array |
||
LC822 | each | EUR 354 |
Description: Lung mucin-producing adenocarcinoma (MPA) tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 40 case/80 cores (1.5mm) |
Tissue array of rectal adenocarcinoma and matched adjacent tissue |
||
RE481 | each | EUR 168 |
Description: Tissue array of rectal adenocarcinoma and matched adjacent tissue, 12 cases/48 cores |
Colonic adenocarcinoma and matched adjacent tissue array |
||
CO481 | each | EUR 198 |
Description: Colonic adenocarcinoma and matched adjacent tissue array, with TNM data, 12 cases/48 cores |
Stomach adenocarcinoma with matched stomach tissue array |
||
ST781 | each | EUR 270 |
Description: Stomach adenocarcinoma with matched stomach tissue array, including pathology grade, TNM and clinical stage, 26 cases/78 cores |
Lung invasive adenocarcinoma (2015 WHO classification) tissue array |
||
LC963 | each | EUR 348 |
Description: Lung invasive adenocarcinoma (2015 WHO classification) tissue array, including pathology grade, TNM and clinical stage(AJCC 8.0), 48 cases/96 cores (1.5mm), replacing BCS04017b |
Lung adenocarcinoma tissue array with normal lung tissue (2015 WHO classification) |
||
BC04119b | each | EUR 270 |
Description: Lung adenocarcinoma tissue array with normal lung tissue (2015 WHO classification), including pathology grade, TNM and clinical stage,30 cases/40 cores, replacing BC04119a |
Colon adenocarcinoma with matched adjacent colon tissue array |
||
CO487 | each | EUR 168 |
Description: Colon adenocarcinoma with matched adjacent colon tissue array, including TNM and pathology grade, 16 cases/48 cores |
Moderately differentiated adenocarcinoma of colon tissue array |
||
CO352a | each | EUR 168 |
Description: Moderately differentiated adenocarcinoma of colon tissue array, including TNM, clinical stage and pathology grade, 35 cases/35 cores |
Stomach adenocarcinoma with matched adjacent normal tissue array |
||
ST1004a | each | EUR 258 |
Description: Stomach adenocarcinoma with matched adjacent normal tissue array, including TNM and pathology grade, 55 cases/100 cores(1.0mm), replacing ST1004 |
Prostate adenocarcinoma with hyperplasia and prostate tissue array |
||
PR1211 | each | EUR 563 |
Description: Prostate adenocarcinoma with hyperplasia and prostate tissue array, including pathology grade, TNM, clinical stage (AJCC 8.0), Gleason grade and Gleason score, 121 cases/121 cores |
Lung adenocarcinoma with matched adjacent normal lung tissue array |
||
LC10013c | each | EUR 306 |
Description: Lung adenocarcinoma with matched adjacent normal lung tissue array, including pathology grade, TNM and clinical stage, 52 cases/100 cores, replacing LC10013b |
Advanced stage of stomach adenocarcinoma with stomach tissue array |
||
ST963a | each | EUR 306 |
Description: Advanced stage of stomach adenocarcinoma with stomach tissue array, including pathology grade, TNM and clinical stage, 95 cases/95 cores, replacing ST963 |
Gallbladder adenocarcinoma with adjacent normal gallbladder tissue array |
||
GA751a | each | EUR 270 |
Description: Gallbladder adenocarcinoma with adjacent normal gallbladder tissue array, including pathology grade, TNM and clinical stage, 75 cases/75 cores (core size 1.5mm), replacing GA751 |
Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control |
||
CO722 | each | EUR 270 |
Description: Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases/72 cores, replacing BC05021 |
Progressive colon adenocarcinoma with matched cancer adjacent tissue array |
||
CO1507 | each | EUR 306 |
Description: Progressive colon adenocarcinoma with matched cancer adjacent tissue array, including ulcer, uplift and infiltrating type adenocarcinoma, with pathology grade, TNM/Stage ( AJCC 8th edition) and MMR (MLH1/PMS2/MSH2/MSH6) IHC results, 75 cases/150cores (core size 1.0mm), Recent Year Collection |
Colon poorly differentiated adenocarcinoma and adjacent normal tissue array |
||
CO725 | each | EUR 270 |
Description: Colon poorly differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases/72 cores, replacing BS05041 |
Lung adenocarcinom tissue array |
||
LC641b | each | EUR 198 |
Description: Lung adenocarcinom tissue array, including invasive papillary adenocarcinoma, invasive mucinous adenocarcinoma and invasive adenocarcinoma with pathology grade, TNM and clinical stage, 64 cases/64 cores, (core size 1.5mm), replacing LC641a |
Prostate adenocarcinoma and normal tissue array with stage and Gleason Scores |
||
PR806 | each | EUR 306 |
Description: Prostate adenocarcinoma and normal tissue array with stage and Gleason Scores, 40 cases/80 cores |
Pancreatic duct adenocarcinoma and normal tissue array with TNM and grade info |
||
PA803 | each | EUR 306 |
Description: Pancreatic duct adenocarcinoma and normal tissue array with TNM and grade info, 40 cases/80 cores |
Stomach adenocarcinoma and normal tissue array with TNM and pathology grade data |
||
ST721 | each | EUR 306 |
Description: Stomach adenocarcinoma and normal tissue array with TNM and pathology grade data, 24 cases/72 cores. |
Pancreatic ductal adenocarcinoma(PDAC) tissue array with 4 normal tissue control from autopsy |
||
PA482 | each | EUR 138 |
Description: Pancreatic ductal adenocarcinoma(PDAC) tissue array with 4 normal tissue control from autopsy, 24 cases/48 cores, with TNM data |
Lung adenocarcinoma (grade III) with adjacent normal lung tissue array (2015 WHO classification) |
||
BS04081a | each | EUR 138 |
Description: Lung adenocarcinoma (grade III) with adjacent normal lung tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 21 cases/63 cores, replacing BS04081 |
Small intestine(most of duodenum) adenocarcinoma tissue array with matched NAT or AT as control |
||
SM1501 | each | EUR 258 |
Description: Small intestine(most of duodenum) adenocarcinoma tissue array with matched NAT or AT as control, including TNM, clinical stage and pathology grade, 50 cases/ 150 cores |
Lung adenocarcinoma with matched normal adjacent or cancer adjacent lung tissue array |
||
LC1531 | each | EUR 258 |
Description: Lung adenocarcinoma with matched normal adjacent or cancer adjacent lung tissue array, including pathology grade, TNM/Stage (AJCC 8th edition), 51 cases/153 cores (core size 1.0mm), replacing LC1504 |
Lung adenocarcinoma with matched cancer adjacent or adjacent normal lung tissue array |
||
LC992a | each | EUR 270 |
Description: Lung adenocarcinoma with matched cancer adjacent or adjacent normal lung tissue array, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 33 cases/99 cores, replacing LC992 |
Pancreatic ductal adenocarcinomas (PDAs) with pancres tissue array |
||
PA243c | each | EUR 270 |
Description: Pancreatic ductal adenocarcinomas (PDAs) with pancres tissue array, including perineural invasion info and pathology grade, TNM and clinical stage, 24 cases/48 cores, replacing PA243b |
Lung Tissue Slide (Adenocarcinoma) |
||
10-106-10um | 10 um | EUR 241.8 |
Lung Tissue Slide (Adenocarcinoma) |
||
10-106-4um | 4 um | EUR 216.6 |
Pancreatic adenocarcinoma with matched adjacent normal or cancer adjacent pancreas tissue array |
||
PA601 | each | EUR 281 |
Description: Pancreatic adenocarcinoma with matched adjacent normal or cancer adjacent pancreas tissue array, including pathology, TNM and clinical stage (reference AJCC 8th version), 37 cases/60 cores |
Stomach adenocarcinoma tissue microarray |
||
ST991b | each | EUR 270 |
Description: Stomach adenocarcinoma tissue microarray, including TNM, clinical stage and pathology grade, 33 cases/ 99cores, replacing ST991a |
Uterus Tissue Slide (Adenocarcinoma) |
||
11-404-10um | 10 um | EUR 241.8 |
Uterus Tissue Slide (Adenocarcinoma) |
||
11-404-4um | 4 um | EUR 216.6 |
Stomach Tissue Slide (Adenocarcinoma) |
||
10-809-10um | 10 um | EUR 241.8 |
Stomach Tissue Slide (Adenocarcinoma) |
||
10-809-4um | 4 um | EUR 216.6 |
Pancreas Tissue Slide (Adenocarcinoma) |
||
11-105-10um | 10 um | EUR 241.8 |
Pancreas Tissue Slide (Adenocarcinoma) |
||
11-105-4um | 4 um | EUR 216.6 |
Colorectal Tissue Slide (Adenocarcinoma) |
||
10-704-10um | 10 um | EUR 241.8 |
Colorectal Tissue Slide (Adenocarcinoma) |
||
10-704-4um | 4 um | EUR 216.6 |
Colorectal Tissue Slide (Adenocarcinoma) |
||
RF10002-06-10um | 10 um | EUR 241.8 |
Colorectal Tissue Slide (Adenocarcinoma) |
||
RF10002-06-4um | 4 um | EUR 216.6 |
Small Intestine Tissue Slide (Adenocarcinoma) |
||
11-815-10um | 10 um | EUR 241.8 |
Small Intestine Tissue Slide (Adenocarcinoma) |
||
11-815-4um | 4 um | EUR 216.6 |
Stomach Tissue Slide (mucinous Adenocarcinoma) |
||
10-810-10um | 10 um | EUR 241.8 |
Stomach Tissue Slide (mucinous Adenocarcinoma) |
||
10-810-4um | 4 um | EUR 216.6 |
Uterus Tissue Slide (Endometrioid Adenocarcinoma) |
||
11-405-10um | 10 um | EUR 241.8 |
Uterus Tissue Slide (Endometrioid Adenocarcinoma) |
||
11-405-4um | 4 um | EUR 216.6 |
Uterus Tissue Slide ( Papillary serous Adenocarcinoma) |
||
11-407-10um | 10 um | EUR 241.8 |
Uterus Tissue Slide ( Papillary serous Adenocarcinoma) |
||
11-407-4um | 4 um | EUR 216.6 |
Stomach Tissue Slide (Signet Ring Cell Adenocarcinoma) |
||
10-811-10um | 10 um | EUR 241.8 |
Stomach Tissue Slide (Signet Ring Cell Adenocarcinoma) |
||
10-811-4um | 4 um | EUR 216.6 |
Human Uterus Tissue Slide (Adenocarcinoma) (5 slides/pk) |
||
HTS-11404 | 1 pk | EUR 343.2 |
Human Stomach Tissue Slide (Adenocarcinoma) (5 slides/pk) |
||
HTS-10809 | 1 pk | EUR 343.2 |
Human Pancreas Tissue Slide (Adenocarcinoma) (5 slides/pk) |
||
HTS-11105 | 1 pk | EUR 343.2 |
Paraffin Tissue Section - Human Lung Tumor: Adenocarcinoma |
||
T2235152-1 | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Colon Tumor: Adenocarcinoma |
||
T2235090-1 | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Liver Tumor: Adenocarcinoma |
||
T2235149-1 | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Appendix Tumor: Adenocarcinoma |
||
T2235006-1 | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Pancreas Tumor: Adenocarcinoma |
||
T2235188-1 | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Prostate Tumor: Adenocarcinoma |
||
T2235201-1 | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Colon Tumor: Adenocarcinoma, MSH |
||
T2235090MSH | 5 slides | EUR 734 |
Paraffin Tissue Section - Human Colon Tumor: Adenocarcinoma, MSS |
||
T2235090MSS | 5 slides | EUR 524 |
Paraffin Tissue Section - Human Rectum Tumor: Adenocarcinoma, MSS |
||
T2235206MSS | 5 slides | EUR 524 |
Paraffin Tissue Section - Human Uterus Tumor: Adenocarcinoma, MSS |
||
T2235274MSS | 5 slides | EUR 524 |
Paraffin Tissue Section - Human Colon Tumor: Adenocarcinoma (Ulcer) |
||
T2235090-3 | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Stomach Tumor: Adenocarcinoma, MSS |
||
T2235248MSS | 5 slides | EUR 524 |
Human Stomach Tissue Slide (Mucinous adenocarcinoma) (5 slides/pk) |
||
HTS-10810 | 1 pk | EUR 343.2 |
Paraffin Tissue Section - Human Breast Tumor: Mucous Adenocarcinoma |
||
T2235086-6 | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Colon Tumor: Adenocarcinoma (Mucoid) |
||
T2235090-2 | 5 slides | EUR 238 |
Human Uterus Tissue Slide (Endometrioid Adenocarcinoma) (5 slides/pk) |
||
HTS-11405 | 1 pk | EUR 343.2 |
Paraffin Tissue Section - Human Thyroid Tumor: Papillary Adenocarcinoma |
||
T2235265-7 | 5 slides | EUR 238 |
Human Uterus Tissue Slide (Papillary serous Adenocarcinoma) (5 slides/pk) |
||
HTS-11407 | 1 pk | EUR 343.2 |
Paraffin Tissue Section - Human Uterus Tumor: Endometrium Adenocarcinoma |
||
T2235274-3 | 5 slides | EUR 238 |
Human Stomach Tissue Slide (Signet Ring Cell Adenocarcinoma) (5 slides/pk) |
||
HTS-10811 | 1 pk | EUR 343.2 |
Paraffin Tissue Section - Human Small Intestine Tumor: Duodenum Adenocarcinoma |
||
T2235226-1 | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Stomach Tumor: Adenocarcinoma, Well Differentiated |
||
T2235248-3 | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Stomach Tumor: Adenocarcinoma Poorly Differentiated |
||
T2235248-1 | 5 slides | EUR 238 |
Rectum adenocarcinoma with normal and adjacent rectum tissues |
||
REF482 | each | EUR 144 |
Description: Rectum adenocarcinoma with normal and adjacent rectum tissues, recent years collection, including pathology grade, TNM and clinical stage ( AJCC 8th Edition), 45 cases/48 cores, replacing RE482 |
Paraffin Tissue Section - Human Gallbladder Tumor: Adenocarcinoma, Poorly Differentiated |
||
T2235118-2 | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Gallbladder Tumor: Adenocarcinoma, Well Differentiated |
||
T2235118-3 | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Pancreas Tumor: Adenocarcinoma, Moderately Differentiated |
||
T2235188-2 | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Stomach Tumor: Adenocarcinoma, Moderately Differentiated |
||
T2235248-2 | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Gallbladder Tumor: Adenocarcinoma, Moderately Differentiated |
||
T2235118-1 | 5 slides | EUR 238 |
Prostate adenocarcinoma |
||
PR781 | each | EUR 306 |
Description: Prostate adenocarcinoma, hyperplasia, NAT and normal tissue array, including pathology grade, TNM/Stage (AJCC 8.0), Gleason grade, Gleason score, 78 cases/78 cores (core size 1.5mm), replacing PR807c. |
Colon adenocarcinoma TMA |
||
CO571 | each | EUR 270 |
Description: Colon adenocarcinoma TMA, 5 samples have matched cancer adjacent tissue samples, including pathology grade, TNM and clinical stage (reference AJCC 8th version) with MMR (MLH1/PMS2/MSH2/MSH6) IHC results, 52 cases/ 57 cores (core size 1.5mm) Recent Year Collection |
Lung large cell carcinoma and adenocarcioma tissue array |
||
LC805a | each | EUR 222 |
Description: Lung large cell carcinoma and adenocarcioma tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores, replacing LC805 |
Human Lung Adenocarcinoma CAFs |
||
CAF07A | 1,000,000 cells | EUR 1492.8 |
Progressive colon adenocarcinoma |
||
CO1506 | each | EUR 258 |
Description: Progressive colon adenocarcinoma, matched cancer adjacent with normal adjacent tissue array, including pathology grade, TNM /Stage ( AJCC 8th version) and MMR (MLH1/PMS2/MSH2/MSH6) IHC results, 50 cases/150cores (core size 1.0mm),Recent Year Collection |
CA 15-3, Human Breast Adenocarcinoma |
||
P1435-1 | each | EUR 130.8 |
CA 15-3, Human Breast Adenocarcinoma |
||
P1435-5 | each | EUR 288 |
Human Endometrial Adenocarcinoma CAFs |
||
CAF01 | 1,000,000 cells | EUR 1467.6 |
Human MCF7 (Breast Adenocarcinoma) lysate |
||
HCL-1219 | 1 mg | EUR 628.8 |
Human PC-3 (Prostate Adenocarcinoma) lysate |
||
HCL-1216 | 100ug | EUR 285.6 |
Human Lung Slide (Adenocarcinoma) (5 slides/pk) |
||
HTS-10106 | 1 pk | EUR 343.2 |
Human SW480 (Colorectal Adenocarcinoma) lysate |
||
HCL-1221 | 100ug | EUR 285.6 |
Human HT-29 (Colorectal Adenocarcinoma) lysate |
||
HCL-1218 | 100ug | EUR 285.6 |
Cancer Antigen 125 Antigen (Human Adenocarcinoma) |
||
VAng-Cr3868-10kU | 10 kU | EUR 505.2 |
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is detected by salt extraction and chromatography. |
Human Caco-2 (Colorectal Adenocarcinoma) lysate |
||
HCL-1223 | 100ug | EUR 285.6 |
Human MDA-MB-361 (Breast Adenocarcinoma) lysate |
||
HCL-1217 | 100ug | EUR 285.6 |
Cancer Antigen 125 Antigen (Human Adenocarcinoma) (> 90%) |
||
VAng-Cr3869-25kU | 25 kU | EUR 967.2 |
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is> 90% by SDS-PAGE. Matched Pair: HM183, HM184, HM185, HM186. |
Cancer of the lung (adenocarcinoma), 80 cases (1.1mm), set 1 |
||
LUC1601 | 1 | EUR 318 |
Description: Lung cancer tissue array (adenocarcinoma), 160 cores from normal (3 cases) and various types of adenocarcinoma (77 cases with TNM staging data) tissues in duplicates. |
Human HeLa (Cervix Adenocarcinoma) Whole Cell Lysate |
||
HCL-2009 | 1 mg | EUR 628.8 |
Human Colorectal Slide (Adenocarcinoma) (5 slides/pk) |
||
HTS-10704 | 1 pk | EUR 343.2 |
GFP Expressing Human Renal Adenocarcinoma Cells (ACHN) |
||
TR04-GFP | 500,000 Cells | EUR 1624.8 |
RFP Expressing Human Renal Adenocarcinoma Cells (ACHN) |
||
TR04-RFP | 500,000 Cells | EUR 1624.8 |
Cancer Antigen CA-125 Antigen (Human Adenocarcinoma) |
||
VAng-Wyb8642-inquire | inquire | Ask for price |
Description: CA-125, Calibrator Grade, Cancer antigen from Human Adenocarcinoma, 500 kIU / mL. |
Human HeLa (Cervix Adenocarcinoma) Cell Nuclear Extract |
||
HCL-2008 | 100ug | EUR 270 |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238) Antibody |
||
BNUB1238-50 | 50uL | EUR 486 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238), 1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC941880-100 | 100uL | EUR 279.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF594 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC941880-500 | 500uL | EUR 654 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF594 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC801880-100 | 100uL | EUR 279.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF680 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC801880-500 | 500uL | EUR 654 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF680 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC701880-100 | 100uL | EUR 279.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF770 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC701880-500 | 500uL | EUR 654 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF770 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC881880-100 | 100uL | EUR 279.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF488A conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC881880-500 | 500uL | EUR 654 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF488A conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC811880-100 | 100uL | EUR 279.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF680R conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC811880-500 | 500uL | EUR 654 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF680R conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC051880-100 | 100uL | EUR 279.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF405M conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC051880-500 | 500uL | EUR 654 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF405M conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC041880-100 | 100uL | EUR 279.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF405S conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC041880-500 | 500uL | EUR 654 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF405S conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC401880-100 | 100uL | EUR 279.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF640R conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC401880-500 | 500uL | EUR 654 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF640R conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNCAP1880-100 | 100uL | EUR 279.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNCAP1880-500 | 500uL | EUR 654 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNCA1880-250 | 250uL | EUR 472.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), APC conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNCP1880-250 | 250uL | EUR 472.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), PerCP conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNCR1880-250 | 250uL | EUR 472.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), RPE conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNCH1880-100 | 100uL | EUR 279.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNCH1880-500 | 500uL | EUR 654 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNCB1880-100 | 100uL | EUR 279.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Biotin conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNCB1880-500 | 500uL | EUR 654 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Biotin conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNUB1880-100 | 100uL | EUR 316.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Concentration: 0.2mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNUB1880-50 | 50uL | EUR 486 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), 1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNUB1880-500 | 500uL | EUR 615.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Concentration: 0.2mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC471880-100 | 100uL | EUR 279.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF647 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC471880-500 | 500uL | EUR 654 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF647 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC611880-100 | 100uL | EUR 279.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF660R conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC611880-500 | 500uL | EUR 654 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF660R conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC431880-100 | 100uL | EUR 279.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF543 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC431880-500 | 500uL | EUR 654 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF543 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC551880-100 | 100uL | EUR 279.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF555 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC551880-500 | 500uL | EUR 654 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF555 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC681880-100 | 100uL | EUR 279.6 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF568 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
||
BNC681880-500 | 500uL | EUR 654 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF568 conjugate, Concentration: 0.1mg/mL |
Human Gastric Adenocarcinoma, Peptide Aptamer, unlabeled |
||
AP-314-U | 5 mg | Ask for price |
MCF-7 Whole Cell Lysate (Human breast adenocarcinoma cells) |
||
MCF7-100 | 100 ug | EUR 196.8 |
MCF-7 Whole Cell Lysate (Human breast adenocarcinoma cells) |
||
MCF7-50 | 50 ug | EUR 153.6 |
Human Gastric Adenocarcinoma, Peptide Aptamer, Biotinylated |
||
AP-314-B | 1 mg | Ask for price |
Human Gastric Adenocarcinoma, Peptide Aptamer, FITC labelled |
||
AP-314-F | 1 mg | Ask for price |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNC941254-100 | 100uL | EUR 238.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF594 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNC941254-500 | 500uL | EUR 652.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF594 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNC801254-100 | 100uL | EUR 238.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF680 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNC801254-500 | 500uL | EUR 652.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF680 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNC811254-100 | 100uL | EUR 238.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF680R conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNC811254-500 | 500uL | EUR 652.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF680R conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNC701254-100 | 100uL | EUR 238.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF770 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNC701254-500 | 500uL | EUR 652.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF770 conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNC881254-100 | 100uL | EUR 238.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF488A conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNC881254-500 | 500uL | EUR 652.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF488A conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNC051254-100 | 100uL | EUR 238.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF405M conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNC051254-500 | 500uL | EUR 652.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF405M conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNC041254-100 | 100uL | EUR 238.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF405S conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNC041254-500 | 500uL | EUR 652.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF405S conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNC401254-100 | 100uL | EUR 238.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF640R conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNC401254-500 | 500uL | EUR 652.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF640R conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNCB1254-100 | 100uL | EUR 238.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), Biotin conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNCB1254-500 | 500uL | EUR 652.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), Biotin conjugate, Concentration: 0.1mg/mL |
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
||
BNCAP1254-100 | 100uL | EUR 238.8 |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |